EyeLock to target healthcare biometrics market

Apr 5, 2018, 2:59 pm EDT | Chris Burt

Categories Biometrics News | Healthcare Biometrics

EyeLock has identified the trillion-dollar healthcare industry as a target market for its iris-based identity authentication solutions, due to the unique characteristics of iris biometrics, and the demand for highly secure touchless authentication, the company has announced.

The healthcare field is a natural extension for the solutions EyeLock currently offers to the financial services, gaming, personal safety, transportation, and automotive industries, according to the announcement. EyeLock cites a report from Grand View Research predicting the global healthcare biometrics market will reach $14.5 billion by 2025, with the migration of healthcare providers to Electronic Health Records (EHR) and the launch of more Healthcare Information Exchanges (HIE) across the network to coordinate care.

Biometrics are increasingly common throughout the healthcare industry, providing controlled access to employee areas, narcotics cabinets, equipment, and areas such as operating and recovery rooms. Iris authentication offers the advantage over of fingerprint and facial recognition of being touchless and not requiring face masks or eye shields to be removed, while providing a superior false acceptance rate, the company says.

“EyeLock provides a solution that has distinct advantages over other commonly used biometrics,” comments Jeff Carter, CEO of EyeLock. “Our focus is to educate healthcare professionals, hospital administrators, and hospital equipment manufacturers as to these very important advantages. Then deliver a solution where the standoff distance, unmatched security with an over 1-in-2.25 trillion false acceptance rate for both eyes and completely touchless interface, create value for these enterprises and the patients they serve. Further, our solutions provide meaningful benefits for inventory and access control of high-value areas such as pharmacy, supplies and patient records.”

The company is currently working with a Canadian provincial healthcare authority, and in talks with healthcare organizations, medical providers and technology solutions integrators.

Carter was appointed EyeLock CEO at the beginning of 2018, and the company also recently relocated its corporate headquarters to a newly renovated office in New York City.